Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Honig

Showing results (101-110 of 273) with videos related to

Pageof 28
Sort By:
Archives of Neurology|September 10, 2008
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer diseaseAdam M Brickman, Lawrence S Honig, Nikolaos Scarmeas, et al.
Journal of Clinical and Experimental Neuropsychology|December 14, 2004
Three-word recall in normal agingMelanie J Chandler, Laura H Lacritz, Antionette R Cicerello, et al.
Neurobiology of Aging|December 5, 2020
Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adultsLok-Kin Yeung, Christiane Hale, Batool Rizvi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 23, 2023
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's diseaseLawrence S Honig, Jerome Barakos, Shobha Dhadda, et al.
Neurobiology of Aging|September 15, 2019
Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adultsLok-Kin Yeung, Christiane Hale, Briana S Last, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLawrence S Honig, Wendy P Gonzalez, Jee Min Kim, et al.
The Journal of Prevention of Alzheimer'S Disease|December 5, 2017
A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's DiseaseN Ketter, E Liu, J Di, et al.
Archives of Neurology|February 1, 1997
Altered amyloid protein processing in platelets of patients with Alzheimer diseaseR N Rosenberg, F Baskin, J A Fosmire, et al.
Plos One|November 8, 2012
Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based studyJonathan A Shaffer, Elissa Epel, Min Suk Kang, et al.
Alzheimer'S Research & Therapy|January 1, 2025
Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohortNeetesh Pandey, Zikun Yang, Basilio Cieza, et al.
Pageof 28

Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
Archives of Neurology|September 10, 2008
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer diseaseAdam M Brickman, Lawrence S Honig, Nikolaos Scarmeas, et al.
Journal of Clinical and Experimental Neuropsychology|December 14, 2004
Three-word recall in normal agingMelanie J Chandler, Laura H Lacritz, Antionette R Cicerello, et al.
Neurobiology of Aging|December 5, 2020
Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adultsLok-Kin Yeung, Christiane Hale, Batool Rizvi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 23, 2023
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's diseaseLawrence S Honig, Jerome Barakos, Shobha Dhadda, et al.
Neurobiology of Aging|September 15, 2019
Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adultsLok-Kin Yeung, Christiane Hale, Briana S Last, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLawrence S Honig, Wendy P Gonzalez, Jee Min Kim, et al.
The Journal of Prevention of Alzheimer'S Disease|December 5, 2017
A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's DiseaseN Ketter, E Liu, J Di, et al.
Archives of Neurology|February 1, 1997
Altered amyloid protein processing in platelets of patients with Alzheimer diseaseR N Rosenberg, F Baskin, J A Fosmire, et al.
Plos One|November 8, 2012
Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based studyJonathan A Shaffer, Elissa Epel, Min Suk Kang, et al.
Alzheimer'S Research & Therapy|January 1, 2025
Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohortNeetesh Pandey, Zikun Yang, Basilio Cieza, et al.
Pageof 28